{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,1,31]],"date-time":"2023-01-31T20:13:32Z","timestamp":1675196012160},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[1995,9,1]],"date-time":"1995-09-01T00:00:00Z","timestamp":809913600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"published-print":{"date-parts":[[1995,9]]},"DOI":"10.1007\/bf01702645","type":"journal-article","created":{"date-parts":[[2005,6,10]],"date-time":"2005-06-10T20:38:14Z","timestamp":1118435894000},"page":"111-117","source":"Crossref","is-referenced-by-count":5,"title":["Establishment and characterization of a novel CD34-positive human myeloid leukemia cell line: MHH225 growing in serum-free culture"],"prefix":"10.1007","volume":"71","author":[{"given":"H. T.","family":"Hassan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Petershofen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Lux","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Fonatsch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Heil","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Freund","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"BF01702645_CR1","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1111\/j.1365-2141.1988.tb02374.x","volume":"69","author":"GC Avanzi","year":"1988","unstructured":"Avanzi GC, Lista P, Giovinazzo B, Miniero R, Saglio G, Benetton G, Coda R, Cattoretti G, Pegoraro L (1988) Selective growth to interleukin-3 of a human leukaemic cell line with megakaryoblastic features. Br J Haematol 69:359\u2013366","journal-title":"Br J Haematol"},{"key":"BF01702645_CR2","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1002\/1097-0142(19910315)67:6<1565::AID-CNCR2820670618>3.0.CO;2-K","volume":"67","author":"E Azumi","year":"1991","unstructured":"Azumi E, Umemoto M, Kubo M (1991) CD34 antigen expression in children with Philadelphia chromosome-positive ALL. Cancer 67:1565\u20131569","journal-title":"Cancer"},{"key":"BF01702645_CR3","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/0145-2126(91)90029-S","volume":"15","author":"S Banavali","year":"1991","unstructured":"Banavali S, Silvestri F, Hulette B (1991) Expression of haemopoietic progenitor cell associated antigen CD34 in CML. Leuk Res 15:603\u2013608","journal-title":"Leuk Res"},{"key":"BF01702645_CR4","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1093\/ajcp\/91.3.265","volume":"91","author":"MJ Borowitz","year":"1989","unstructured":"Borowitz MJ, Gockerman JP, Moore JO (1989) Clinicopathologic and cytogenetic features of CD34 (My10) positive acute nonlymphocytic leukemia. Am J Clin Pathol 91:265\u2013270","journal-title":"Am J Clin Pathol"},{"key":"BF01702645_CR5","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1002\/ijc.2910260608","volume":"26","author":"C Fonatsch","year":"1980","unstructured":"Fonatsch C, Schaadt M, Kirchner H, Diehl V (1980) A possible correlation between the degree of karyotype aberrations and the rate of sister chromatid exchanges in lymphoma lines. Int J Cancer 26:749\u2013756","journal-title":"Int J Cancer"},{"key":"BF01702645_CR6","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1111\/j.1365-2141.1990.tb06365.x","volume":"76","author":"RB Geller","year":"1990","unstructured":"Geller RB, Zahurak M, Hurwitz CA (1990) Prognostic significance of immunophenotype in adults with AML: the significance of the stem cell glycoprotein CD34 (My10). Br J Haematol 76:340\u2013344","journal-title":"Br J Haematol"},{"key":"BF01702645_CR7","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/0046-8177(92)90006-O","volume":"23","author":"CA Hanson","year":"1992","unstructured":"Hanson CA, Ross CW, Schnitzer B (1992) AntiCD34 immunoperoxidase staining in paraffin sections of acute leukaemia: comparison with flow cytometric immunophenotype. Hum Pathol 23:26\u201332","journal-title":"Hum Pathol"},{"key":"BF01702645_CR8","first-page":"277","volume-title":"The pharmacology of cell differentiation","author":"HT Hassan","year":"1993","unstructured":"Hassan HT (1993) Synergism between differentiation-inducing agents: preclinical and clinical studies in myeloid leukaemia. In: Rifkind R (ed) The pharmacology of cell differentiation. Elsevier, Amsterdam, pp 277\u2013294"},{"key":"BF01702645_CR9","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1159\/000226865","volume":"47","author":"HT Hassan","year":"1990","unstructured":"Hassan HT, Rees JKH (1990) The relation between age and blast cell differentiation in acute myeloid leukaemic patients. Oncology 47:439\u2013442","journal-title":"Oncology"},{"key":"BF01702645_CR10","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1007\/978-3-642-48715-6_40","volume-title":"Cytokines in hemopoeisis, oncology and AIDS. II","author":"HT Hassan","year":"1992","unstructured":"Hassan HT, Maurer HR (1992) Effects of recombinant human cytokines on cytarabine activity in K562 human myeloid leukaemia cells. In: Freund M, et al (eds) Cytokines in hemopoeisis, oncology and AIDS. II. Springer, Berlin Heidelberg New York, pp 313\u2013319"},{"key":"BF01702645_CR11","first-page":"481","volume":"11","author":"HT Hassan","year":"1991","unstructured":"Hassan HT, Veit AF, Maurer HR (1991) Recombinant human GM-CSF significantly enhances the cytostatic activity of cell-cycle-specific antileukaemic drugs in HL-60 human myeloid leukaemia clonogenic cells in agar capillary clonogenic microassay. Anticancer Res 11:481\u2013486","journal-title":"Anticancer Res"},{"key":"BF01702645_CR12","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1002\/hon.2900120203","volume":"11","author":"HT Hassan","year":"1994","unstructured":"Hassan HT, Grell S, Borrmann-Danso U, Freund M (1994) Interleukin-4 inhibits proliferation of human leukaemic megakaryoblastic cells. Hematol Oncol 11:61\u201366","journal-title":"Hematol Oncol"},{"key":"BF01702645_CR13","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1111\/j.1365-2141.1988.tb04174.x","volume":"68","author":"G Heil","year":"1988","unstructured":"Heil G, Ganser A, Raghavachar A, Kurrle E, Heit W, Hoelzer D, Heimpel H (1988) Induction of myeloperoxidase in five cases of acute unclassified leukaemia. Br J Haematol 68:23\u201332","journal-title":"Br J Haematol"},{"key":"BF01702645_CR14","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1182\/blood.V80.2.470.470","volume":"80","author":"K Kita","year":"1992","unstructured":"Kita K, Nakase K, Miwa M (1992) Phenotypical characteristics of acute myelogenous leukaemia associated with the t(8;21)(q22;q22) chromosomal abnormality: frequent expression of immature B-cell antigen CD19 together with stem cell antigen CD34. Blood 80:470\u2013477","journal-title":"Blood"},{"key":"BF01702645_CR15","first-page":"341","volume":"51","author":"N Komatsu","year":"1991","unstructured":"Komatsu N, Nakauchi H, Miwa A, Ishihara T, Eguchi M, Moroi M, Okada M, Sato Y, Wada H, Yawata Y (1991) Establishment and characterisation of a human leukemic cell line with megakaryocytic features: dependency on GM-CSF, IL-3 or erythropoietin for growth and survival. Cancer Res 51:341\u2013348","journal-title":"Cancer Res"},{"key":"BF01702645_CR16","first-page":"1203","volume":"6","author":"EJ Lee","year":"1992","unstructured":"Lee EJ, Yang J, Leavitt RD (1992) The significance of CD34 and TdT determinations in patients with untreated de novo acute myeloid leukaemia. Leuk 6:1203\u20131209","journal-title":"Leuk"},{"key":"BF01702645_CR17","first-page":"261","volume":"4","author":"Y Matsuo","year":"1991","unstructured":"Matsuo Y, Adachi T, Tsubota T, Imanshi J, Minowada J (1991) Establishment and characterisation of a novel megakaryoblastic cell line, MOLM-1, from a patient with CML. Hum Cell 4:261\u2013264","journal-title":"Hum Cell"},{"key":"BF01702645_CR18","volume-title":"Catalog of chromosome aberrations in cancer","author":"F Mitelman","year":"1991","unstructured":"Mitelman F (1991) Catalog of chromosome aberrations in cancer. Wiley-Liss, New York"},{"key":"BF01702645_CR19","first-page":"373a","volume":"82","author":"D Morgan","year":"1993","unstructured":"Morgan D (1993) Differential cytokine response of human lineage-specific progenitor cell lines. Blood 82:373a, 1477","journal-title":"Blood"},{"key":"BF01702645_CR20","doi-asserted-by":"crossref","first-page":"2860","DOI":"10.1182\/blood.V78.11.2860.2860","volume":"78","author":"DA Morgan","year":"1991","unstructured":"Morgan DA, Gumucio DL, Brodsky I (1991) GM-CSF-dependent growth and erythropoietin-induced differentiation of a human cell line MB-02. Blood 78:2860\u20132871","journal-title":"Blood"},{"key":"BF01702645_CR21","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1182\/blood.V84.4.1085.1085","volume":"84","author":"MA Mouthon","year":"1994","unstructured":"Mouthon MA, Freund M, Titeux M, Katz A, Guichard J, Breton-Gorius J, Vainchenker W (1994) Growth and differentiation of the human megakaryoblastic cell fine ELF-153: a model for early stages of megakaryocytopoiesis. Blood 84:1085\u20131097","journal-title":"Blood"},{"key":"BF01702645_CR22","doi-asserted-by":"crossref","first-page":"425","DOI":"10.3109\/10428199209049798","volume":"7","author":"H Myint","year":"1992","unstructured":"Myint H, Lucie NP (1992) The prognosis of the CD34 antigen in AML. Leuk Lymphoma 7:425\u2013429","journal-title":"Leuk Lymphoma"},{"key":"BF01702645_CR23","doi-asserted-by":"crossref","first-page":"2780","DOI":"10.1182\/blood.V83.10.2780.2780","volume":"83","author":"J Pedersen-Bjergaard","year":"1994","unstructured":"Pedersen-Bjergaard J, Rowley JD (1994) The balanced and the unbalanced chromosome aberrations of AML may develop in different ways and may contribute differently to malignant transformation. Blood 83:2780\u20132786","journal-title":"Blood"},{"key":"BF01702645_CR24","first-page":"1663","volume":"7","author":"H Rieder","year":"1993","unstructured":"Rieder H, Kolbus U, Koop U, Ludwig W-D, Stollmann-Gib-bels B, Fonatsch C (1993) Translocation t(1;22) mimicking t(1;19) in a child with acute lymphoblastic leukaemia as revealed by chromosome painting. Leuk 7:1663\u20131666","journal-title":"Leuk"},{"key":"BF01702645_CR25","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1007\/BF00490073","volume":"41","author":"F Roels","year":"1975","unstructured":"Roels F, Wisse E, Brest B De, Van der MJ (1975) Cytochemical discrimination between catalases and peroxidases using diaminobenzidine. Histochemistry 41:281\u2013312","journal-title":"Histochemistry"},{"key":"BF01702645_CR26","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1016\/0888-7543(92)90310-O","volume":"12","author":"AB Satterthwaite","year":"1992","unstructured":"Satterthwaite AB, Burn TC, Le Baeu MM, Tenen DG (1992) Structure of the gene encoding CD34 a human haemopoietic stem cell antigen. Genomics 12:788\u2013794","journal-title":"Genomics"},{"key":"BF01702645_CR27","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1111\/j.1365-2249.1991.tb05699.x","volume":"85","author":"C Schmitt","year":"1991","unstructured":"Schmitt C, Eaves CJ, Landsdorf PM (1991) Expression of CD34 on human B-cell precursors. Clin Exp Immunol 85:168\u2013173","journal-title":"Clin Exp Immunol"},{"key":"BF01702645_CR28","first-page":"265","volume":"77","author":"F Silvestri","year":"1992","unstructured":"Silvestri F, Banavali S, Baccarani M, Preisler HD (1992) The CD34 haemopoietic progenitor cell associated antigen: biology and clinical applications. Haematologica (Pavia) 77:265\u2013273","journal-title":"Haematologica (Pavia)"},{"key":"BF01702645_CR29","first-page":"393","volume":"6","author":"E Solary","year":"1992","unstructured":"Solary E, Casanovas RO, Campos: Surface markers in adult (1992) correlation of CD19+, CD34+ and CD14+ DR-phenotypes with shorter survival. Leukemia 6:393\u2013399","journal-title":"Leukemia"},{"key":"BF01702645_CR30","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1111\/j.1365-2141.1985.tb07399.x","volume":"60","author":"B Stollmann","year":"1985","unstructured":"Stollmann B, Fonatsch C, Havers W (1985) Persistant Epstein-Barr virus infection associated with monosomy 7\/ chromosome 3 abnormality in childhood myeloproliferative disorders. Br J Haematol 60:183\u2013196","journal-title":"Br J Haematol"},{"key":"BF01702645_CR31","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1002\/ajh.2830390205","volume":"39","author":"SA Sullivan","year":"1992","unstructured":"Sullivan SA, Marsden KA, Lowenthal RM (1992) Circulating CD34+ cells: an adverse prognostic factor in myelodysplastic syndromes. Am J Hematol 39:96\u2013101","journal-title":"Am J Hematol"},{"key":"BF01702645_CR32","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1111\/j.1365-2141.1992.tb08168.x","volume":"81","author":"X Thomas","year":"1992","unstructured":"Thomas X, Campos L, Archimbaud E (1992) Surface marker expression in AML at first relapse. Br J Haematol 81:40\u201344","journal-title":"Br J Haematol"},{"key":"BF01702645_CR33","first-page":"122a","volume":"Suppl","author":"A Zipursky","year":"1993","unstructured":"Zipursky A, Vanek W, Grunberger T, Brown EJ, Wang H, Sutherland R, Yeo E, Cohen A, Freedman M (1993) A megakaryoblastic cell line from a patient with Down syndromeacute megakaryoblastic leukemia (DS-AMKL): in vitro differentiation of megakaryoblasts. Blood [Suppl]:122a, 474","journal-title":"Blood"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01702645.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF01702645\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01702645","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,7]],"date-time":"2020-04-07T16:13:34Z","timestamp":1586276014000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF01702645"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1995,9]]},"references-count":33,"journal-issue":{"issue":"3","published-print":{"date-parts":[[1995,9]]}},"alternative-id":["BF01702645"],"URL":"https:\/\/doi.org\/10.1007\/bf01702645","relation":{},"ISSN":["0939-5555","1432-0584"],"issn-type":[{"value":"0939-5555","type":"print"},{"value":"1432-0584","type":"electronic"}],"subject":[],"published":{"date-parts":[[1995,9]]}}}